04/26/2026
https://www.doximity.com/articles/eeaebfa1-cf0e-45a9-8d57-13d0b2c0b04f
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug.